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Summary
 
Mucosal surfaces are protected specifically by secretory immunoglobulin A (SIgA) and SIgM
generated through external translocation of locally produced dimeric IgA and pentameric IgM.
Their active transport is mediated by the epithelial polymeric Ig receptor (pIgR), also called the
transmembrane secretory component. Paracellular passive external transfer of systemic and lo-
cally produced antibodies also provides mucosal protection, making the biological importance
of secretory immunity difficult to assess. Here we report complete lack of active external IgA
and IgM translocation in pIgR knockout mice, indicating no redundancy in epithelial transport
mechanisms. The knockout mice were of normal size and fertility but had increased serum IgG
levels, including antibodies to 
 
Escherichia coli
 
, suggesting undue triggering of systemic immu-
nity. Deterioration of their epithelial barrier function in the absence of SIgA (and SIgM) was
further attested to by elevated levels of albumin in their saliva and feces, reflecting leakage of
serum proteins. Thus, SIgA did not appear to be essential for health under the antigen exposure
conditions of these experimental animals. Nevertheless, our results showed that SIgA contrib-
utes to maintenance of mucosal homeostasis. Production of SIgA might therefore be a variable
in the initiation of human immunopathology such as inflammatory bowel disease or gluten-
sensitive enteropathy.
Key words: IgA, secretory • receptors, polymeric immunoglobulin • secretory component • 
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T
 
he existence of an adaptive secretory immune system,
based mainly on active external transport of locally
produced dimeric IgA and operating fairly independently
of systemic immunity, has been known for several decades
(1, 2). It is believed that secretory (S)IgA
 
1
 
 and, to a lesser
extent, SIgM antibodies enhance the epithelial barrier
function by a mechanism termed immune exclusion (3).
These antibodies, which may act both within secretory ep-
ithelia and at mucosal surfaces (4–6), are generated by a
unique cooperation between two distinct cell types (7, 8):
J chain–expressing plasma cells that produce polymeric
(p)IgA (mainly dimers) or pentameric IgM, and secretory
epithelial cells that express the pIgR, also known as the
transmembrane secretory component (SC). This receptor
mediates active transport of pIgA and pentameric IgM to
exocrine secretions (9, 10). Cleavage of unoccupied and
ligand-complexed pIgR, respectively, releases free SC and
SIgA or SIgM into the lumen.
Induction of a secretory immune response is often asso-
ciated with elevation of corresponding serum IgG and IgA
(in humans mainly monomeric) antibodies (6). These anti-
bodies can reach external secretions by passive paracellular
diffusion and may thus contribute to immune exclusion (3).
As a consequence, it is often difficult if not impossible to
distinguish between the role of secretory versus systemic
immunity in local defense. Distinction between the effects
of these types of protective mechanisms would be impor-
tant for rational design of vaccines and understanding of
immunopathology in important mucosal disorders, includ-
ing inflammatory bowel disease (IBD). Therefore, to iden-
tify the effect of secretory immunity, we generated mice
lacking functional pIgR and hence active external transport
of pIgA and pentameric IgM.
 
1
 
Abbreviations used in this paper: 
 
IBD, inflammatory bowel disease; p, poly-
meric; S, secretory; SC, secretory component. 
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Materials and Methods
 
Generation of pIgR Knockout Mice.
 
The polymeric Ig receptor
locus (PIGR) was isolated from a genomic sv129 library in
EMBL4 by probing with radiolabeled oligonucleotides based on
the rat pIgR cDNA sequence. The targeting vector included (5
 
9
 
to 3
 
9
 
): a 1.9-kb upstream arm; a 
 
neo
 
R
 
 cassette inserted at the PmlI
site in exon 3, disrupting the noncovalent pIg-binding site; a 7.5-kb
downstream arm; and a herpes simplex virus thymidine kinase
gene for negative selection of nonhomologous recombinants.
E14.1 embryonic stem cells were electroporated with SalI linear-
ized vector, and homozygous mutant mice were generated as de-
scribed previously (11). 129/OLa 
 
3
 
 C57BL/6 black mixed males,
5–6 mo old, were kept in accordance with institutional guidelines
and used for all analyses.
 
DNA and RNA Analysis.
 
Southern blots were performed with
10 
 
m
 
g of embryonic stem cell DNA or tail biopsy DNA digested
with HindIII, separated by agarose gel electrophoresis, and probed
with a 1.4-kb genomic NcoI fragment adjacent to the targeting
construct. RNA was isolated from the small intestine with RNAesy
kit (QIAGEN, Inc.), and 10 
 
m
 
g was separated on a formaldehyde
agarose gel, blotted, and hybridized to radiolabeled murine pIgR
cDNA (12) (gift from C.S. Kaetzel, University of Kentucky,
Lexington, KY). For reverse transcription PCR, 500 ng of RNA
was primed with oligo dT. PCR was performed with pigr-e2 for
5
 
9
 
-GCTCTACTTGTTCACGCTC versus pigr-e4.rev 5
 
9
 
-TTT-
CTGCCTATGTCCTTTG. The products were sequenced di-
rectly with a cycle sequencing kit (Amersham International PLC).
 
Immunohistochemistry.
 
Excised organs were washed briefly in
ice cold PBS, fixed overnight in cold 70% ethanol, and paraffin
embedded (56–57
 
8
 
C, 3–4 h) after graded dehydration. Primary
rabbit antibody reagents against mouse IgA and mouse IgG were
obtained commercially as fluorescein (Zymed Labs., Inc.) and
Texas Red (Jackson ImmunoResearch Labs., Inc.) conjugates, re-
spectively. Rabbit polyclonal antibody to murine SC (gift from B.
Corthesy, Centre Hospitalier Universitaire Vaudois, Lausanne,
Switzerland) was used with a secondary rhodamine-labeled donkey
IgG anti–rabbit conjugate (Jackson ImmunoResearch Labs., Inc.).
Optimal working concentrations of all immune reagents were de-
termined by performance testing on relevant tissue substrates.
 
Sampling and Analysis of Body Fluids.
 
Peripheral blood, whole
saliva, extract of small intestinal wick-retrieved mucus, and ex-
tract of feces were sampled and processed as described (13).
ELISA was used to determine IgA, IgG (13), and albumin (Bethyl
Labs.) concentrations. ELISA was also used to measure serum IgG
antibodies to formalin-inactivated murine 
 
Escherichia coli
 
 and 
 
Lac-
 
tobacillus
 
 isolates (courtesy of T. Midtvedt, Karolinska Institutet,
Stockholm, Sweden) and to wheat gluten (Sigma Chemical Co.).
For Western blots, the indicated amount of sample was separated by
nonreducing SDS-PAGE, transferred to nitrocellulose, and probed
with polyclonal rabbit antiserum against murine IgA (DAKO
Corp.) or murine SC. Secondary antibody was horseradish peroxi-
dase–conjugated goat anti–rabbit IgG used at 1:3,000 followed by
enhanced chemiluminescence revealing reaction (ECL; Amersham
Corp.). All incubations were in PBS with 0.05% Tween.
 
Results and Discussion
 
Lack of Active Epithelial and Hepatic IgA Transport in pIgR
Knockout Mice.
 
A targeting vector with a disruption in
exon 3 that encodes the ligand-binding extracellular recep-
tor domain 1 (D1) was used to knock out the pIgR gene
(locus PIGR) in mice (Fig. 1 A). Wild-type and mutant
chromosomes were distinguished by Southern blots (Fig. 1
B). To test expression of the mutant allele, we performed
Northern blots with small intestinal RNA from wild-type
and pIgR
 
2
 
/
 
2
 
 mice (Fig. 1 C); the latter were expected to
encode mRNA 1.7 kb larger than wild type, but mutant
pIgR mRNA was in fact smaller and less abundant. Clon-
ing and sequencing of pIgR cDNAs from pIgR
 
2
 
/
 
2
 
 mice
revealed two alternatively spliced mRNA forms (one in
frame and one out of frame) that both deleted pIgR D1.
Thus, there was a possibility that a truncated receptor lacking
D1 might be produced, but this variant would not bind IgA.
Sections of small intestinal mucosa from pIgR
 
2
 
/
 
2
 
 and
wild-type mice were immunostained for pIgR/SC, IgA,
and IgG. The wild-type mice had relatively less interstitial
IgA in their lamina propria than the pIgR
 
2
 
/
 
2
 
 mice (Fig. 2,
top panels). Conversely, the epithelium was IgA positive
only in the wild-type mice; the staining was intensified at the
apical face, indicating active external transport of pIgA.
Thus, the pIgR
 
2
 
/
 
2
 
 mice showed no evidence of intracellular
IgA transport despite increased concentration of subepithelial
IgA. Lack of epithelial transport was also evident for IgM
(not shown). Likewise, immunostaining for SC demon-
strated abundant cytoplasmic expression both in crypt and
surface epithelium of wild-type mice, whereas only occa-
Figure 1. Generation of pIgR2/2 mice. (A) The PIGR locus and gene targeting strategy. A neoR cassette was inserted in exon 3, disrupting the non-
covalent pIg-binding site, and a herpes simplex virus thymidine kinase gene was inserted downstream for negative selection of nonhomologous recombi-
nants. (B) Southern blot of tail DNA from wild-type, heterozygote, and pIgR2/2 (1/1, 1/2, and 2/2, respectively) mice probed with the 1.4-kb
NcoI fragment indicated in A. (C) Northern blot of RNA extracted from small intestines of 1/1 and 2/2 mice probed with murine pIgR cDNA (gift
from C. Kaetzel). 
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sional faint crypt staining was seen in the pIgR
 
2
 
/
 
2
 
 mice
with a polyclonal reagent directed against D1–D5 (Fig. 2,
bottom panels). This inconsistent expression might be spu-
rious but could reflect expression of mutant pIgR lacking
D1 and therefore not represent functional receptor protein.
Immunofluorescence staining revealed a similar picture in
colon mucosa and also confirmed that there was no vesicu-
lar IgA transport through hepatocytes in pIgR
 
2
 
/
 
2
 
 mice in
contrast to wild-type mice (not shown). Thus, the hepatic
pIgR-mediated “IgA pump” was lacking in pIgR
 
2
 
/
 
2
 
 mice.
Similarly, the hepatic IgA transport was reported to be ab-
sent in J chain knockout mice because pIgA and pentam-
eric IgM require this peptide for binding to pIgR (7, 14).
 
Epithelial Leakiness and Systemic IgG Antibody Production
against E. coli in pIgR Knockout Mice.
 
To measure the effect
of pIgR mutation on total transfer of IgA to secretions com-
pared with that of IgG and albumin (which are not actively
transported), we tested serum, whole saliva, small intestinal
secretions, and fecal extracts from pIgR
 
2
 
/
 
2
 
 and wild-type
mice by ELISA (Fig. 3 A). As expected, pIgR
 
2
 
/
 
2
 
 animals
had grossly elevated levels of IgA in serum due to lack of
the hepatic IgA pump operating in rodents (15). Western
blot analysis confirmed that this IgA was mostly polymeric
(Fig. 4 A). More surprisingly, pIgR
 
2
 
/
 
2 
 
animals also had in-
creased levels of serum IgG. This elevation could be caused
by less efficient IgG degradation due to catabolic competi-
tion with the elevated serum IgA. Alternatively, increased
serum IgG in the knockout mice might reflect enhanced
triggering of their systemic immune systems. We found
that the serum IgG elevation was due in part to increased
levels of antibodies to 
 
E
 
.
 
 coli
 
 (Fig. 3 B), whereas there was
no difference in the IgG antibody response to
 
 Lactobacillus
 
or gluten (their main dietary protein). This finding pro-
vided strong support for a selective stimulation of systemic
IgG response to 
 
E
 
.
 
 coli
 
 in the absence of SIgA (and SIgM).
The wide scatter of the IgG response among the knockout
mice was not surprising in view of similar variability of in-
testinal immunopathology induced by gut bacteria in dif-
ferent cytokine-deficient and transgenic rodents (16, 17).
There was no statistical difference in the salivary IgA lev-
els of wild-type and pIgR animals, whereas both IgG and
albumin levels were elevated in saliva from the knockout
mice, suggesting epithelial leakage of serum-derived pro-
teins (Fig. 3 A). Each pIgR
 
2
 
/
 
2
 
 mouse had higher levels of
salivary IgG than IgA, whereas each wild-type mouse had
more IgA than IgG. Furthermore, there was good correla-
tion between albumin and both IgA and IgG levels in saliva
of the knockout mice (
 
r
 
 5 
 
0.94,
 
 P 
 
5 
 
0.02 for both), sup-
porting the idea of increased external bulk diffusion of se-
rum proteins. In wild-type mice, however, there was only
a significant correlation between the much lower levels of
albumin and IgG (
 
r
 
 5 
 
0.89,
 
 P 
 
5 
 
0.03), presumably reflect-
ing that their salivary IgA did not depend on leakage of se-
rum IgA but rather on generation of SIgA.
At the mucosal surface in the small intestine, IgA con-
centrations were lower in pIgR
 
2
 
/
 
2
 
 than in wild-type mice,
despite elevated serum (and lamina propria) levels in the
former. This contrasted with findings in J chain–deficient
mice that showed no difference in IgA levels at this site
compared with wild-type animals (18), although their fecal
and biliary levels of IgA were reported to be significantly
repressed (14). This disparity in the J chain knockout mice
was proposed to be due to a putative alternative active epi-
thelial transport mechanism for monomeric IgA and pIgA
operating selectively at certain secretory sites (18). How-
ever, we found that small intestinal IgG levels were about
twofold higher in the pIgR
 
2
 
/
 
2 
 
than in the wild-type mice,
clearly reflecting the difference in their serum IgG levels
(Fig. 3 A). The high levels of albumin in the same samples
also suggested a significant bulk leakage of serum proteins
across the epithelium.
We believe that the harsh physical manipulation of the
small intestine performed to collect secretions at the lumi-
nal surface, used in both this study and the J chain knock-
out study (18), considerably increased the leakage of pro-
teins from the lamina propria. Thus, although the use of
wicks to retrieve secretions may be appropriate for the de-
Figure 2. Lack of epithelial IgA transport in pIgR2/2 mice. Immuno-
fluorescence staining of IgA, IgG, and pIgR/SC in tissue sections from the
small intestine of knockout (2/2; right panels) and wild-type (1/1; left
panels) mice. Top panels: paired staining of IgA (fluorescein, green) and
IgG (Texas Red) in cross section of crypt region. Note lack of IgA in ep-
ithelium and increased level of interstitial IgA in pIgR2/2 mice (seen as
yellow color due to mixing of green with red). Bottom panels: SC stain-
ing at low magnification showing abundant pIgR/SC expression in both
crypt and villous epithelium of wild-type mice but only occasional faint
staining deep in the crypts of pIgR2/2 mice. Small intestinal mucosa is
shown at full height (note obliquely cut villi in left panel due to tilted tis-
sue orientation). 
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termination of changes in specific production of antibodies
along the intestinal tract, it may not be suitable to differ-
entiate between luminal IgA derived via active or passive
(in vivo
 
 
 
or in vitro) external transfer. This is in good agree-
ment with the documented liability of mucosal epithelia to
allow profuse external bulk transfer of serum proteins after
local irritation (19).
The IgA levels of fecal extracts were significantly lower in
pIgR
 
2
 
/
 
2
 
 than in wild-type mice, which probably was ex-
plained both by abrogated active transport and reduced stabil-
ity of the paracellularly diffused IgA (compared with actively
transported SIgA) in the knockout mice (see below). A similar
disparity between small intestinal mucus and fecal extracts was
reported in J chain knockout mice compared with wild-type
mice (14, 18). Importantly, the fecal levels of albumin were
much higher in the pIgR
 
2
 
/
 
2
 
 than in the wild-type mice, sug-
gesting increased epithelial protein leakage even in the un-
touched large bowel, as was also noted for saliva (Fig. 3 A). 
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Nature of IgA in External Secretions of pIgR Knockout
Mice.
 
We performed Western blots to assess the molecu-
lar form of IgA collected from various compartments (Fig.
4, A and B). Both monomeric and polymeric forms of IgA
were present in serum from wild-type mice, whereas their
salivary IgA was mainly polymeric (Fig. 4 A). By contrast,
serum from pIgR
 
2
 
/
 
2
 
 mice contained almost exclusively
polymers of IgA, and their salivary IgA was of a similar mo-
lecular form. Fecal and small intestinal IgA from both wild-
type and pIgR
 
2
 
/
 
2
 
 mice migrated as a smear, suggesting
some degradation, and the largest forms showed a size con-
sistent with intact SIgA only in the wild-type mice. This
was confirmed by blotting with an antibody to SC (Fig. 4
B). Together, these results demonstrated that only exocrine
IgA from wild-type mice contained SIgA, whereas IgA in
the secretions of pIgR
 
2
 
/
 
2
 
 mice appeared to be derived
from serum and interstitial fluid by passive external diffu-
sion. As alluded to above, it is well known that such para-
cellular bulk transfer of proteins is greatly enhanced when
mucous membranes are irritated (19), which was unavoid-
able in the small intestinal sampling procedure.
 
Possible Consequences of Absent Epithelial IgA Transport.
 
The functional basis of the now internationally accepted
common model for receptor-mediated epithelial transport
of pIgA and pentameric IgM into external secretions was
proposed by this laboratory 25 years ago (8, 20, 21). It
stated that J chain–expressing local plasma cells produce
pIgA and pentameric IgM that, by virtue of their J chain
incorporation, contain a noncovalent binding site for
pIgR/SC. Mostov et al. first demonstrated in 1980 that
free SC could be derived from a transmembrane precursor
by endoproteolytic receptor cleavage (22). Subsequent
cDNA cloning of transmembrane rabbit SC (23) and its
functional expression in polarized Madin-Darby canine
kidney cells (24) demonstrated that SC indeed operated as
pIgR in being capable of external pIgA transport in vitro.
Thus, SIgA and SIgM are generated by pIgR-mediated
ligand transport across secretory epithelial cells and subse-
quent release into secretions after receptor cleavage. Sec-
ondary covalent bonding of SC to pIgA makes SIgA the
most stable antibody operating in external secretions (6, 25).
The relatively minor differences observed between
pIgR
 
2
 
/
 
2
 
 and wild-type mice in small intestinal mucus and
salivary IgA levels showed that pIgR function is not essen-
tial for external IgA transfer. Thus, our results documented
that pIgA, like IgG and monomeric IgA, can reach secre-
tions by paracellular leakage and that this transfer is in-
creased by epithelial irritation. External defense resulting
from such passive luminal supply of antibodies probably ex-
plained that the intestinal mucosae of the knockout mice
generally exhibited no histological signs of inflammation
and that the animals were of normal size and fertility (data
Figure 4. Increased pIgA serum level but
lack of SIgA in pIgR2/2 mice. Western blot of
IgA in serum and secretions from pIgR2/2
(2/2) and wild-type (1/1) mice. The indi-
cated amounts of samples (in microliters for se-
cretions and micrograms dry weight for feces)
were separated by SDS-PAGE, transferred to
nitrocellulose, and probed with antibody to a
chain (A) or to SC as a marker of SIgA (B).
The positions of migration of purified human
SC and SIgA are indicated. Intest., intestine.
Figure 3. Altered Ig and albumin levels in
serum and secretions of pIgR2/2 mice. (A)
Levels of IgA, IgG, and albumin in pIgR2/2
(2/2,  j) and wild-type (1/1,  m) mice
were measured by ELISA in serum, saliva,
mucus extract from the small intestine, and
extract of feces. Statistical analysis was per-
formed with the Mann-Whitney test (w, P ,
0.05 and ww, P , 0.005). (B) Relative titers
of serum IgG antibodies against E. coli, Lacto-
bacillus, or gluten.920 pIgR-deficient Mice
not shown). Nevertheless, their defective epithelial barrier
function, as revealed by increased albumin levels at un-
touched mucosal surfaces (that is, in saliva and feces) and
increased IgG anti–E. coli levels in serum, supported the
notion that pIgR normally executes an important function
in maintaining mucosal homeostasis.
Although not shown here, it is possible that increased
bacterial colonization and related irritation of epithelial sur-
faces explained the “leaky phenotype” of our knockout
mice. This possibility would harmonize with the striking
role shown for SIgA from breast milk in inhibiting translo-
cation of E. coli from the gut lumen to mesenteric lymph
nodes in neonatal rabbits (26). Furthermore, the markedly
reduced fecal IgA levels in the knockout mice confirmed a
role of bound SC to stabilize pIgA in secretions (25). Also,
apical recycling of pIgR–pIgA complexes has been re-
ported (10), and the strong apical IgA staining of wild-type
intestinal epithelium (Fig. 2) suggested that pIgA is nor-
mally associated with the epithelial cells for some time, in
keeping with its ability to neutralize intracellular virus dur-
ing pIgR-mediated transcytosis (4, 27–29). Thus, in addi-
tion to mediating active external antibody transport, the
function of pIgR/SC is most likely important at various
other critical points of mucosal defense (5).
A reduced epithelial barrier function leading to abroga-
tion of immunological tolerance against normally innocu-
ous antigens, including dietary proteins and components of
the indigenous bacterial flora, appears to be a significant
immunopathogenic mechanism in several important mu-
cosal disorders such as gluten-sensitive enteropathy (celiac
disease) (30) and IBD (31, 32). One marker of this unto-
ward development is lack of mucosal integrity (33) and in-
creased production of IgA and IgG antibodies to normally
encountered luminal antigens, particularly against gluten in
celiac disease (30) and E. coli in IBD (31, 34). Complete
lack of pIgR has not been convincingly identified in hu-
mans, perhaps reflecting evolutionary avoidance of such a
deficiency (35). However, our results showed that this re-
ceptor is not essential for the health of mice in a conven-
tional laboratory animal facility. This might reflect redun-
dancy of SIgA in terms of local immunity under such
conditions, but its presence might nevertheless protect
against development of mucosal immunopathology over
time. Thus, individuals with selective IgA deficiency show
an increased frequency of mucosal disorders such as celiac
disease (36) and IBD, particularly Crohn’s disease (Ham-
marström, L., personal communication), despite generally
eliciting compensatory SIgM responses (35). Also, in-
creased mucosal leakiness is observed in patients with AIDS
who have defective production of intestinal IgA antibodies
against the infecting virus (37, 38).
In conclusion, this study provides the first direct evi-
dence that generation of SIgA and SIgM has a basic impact
on the epithelial barrier function. It may therefore be an
important factor for sustenance of mucosal homeostasis and
thus a variable in local defense and immunopathology. Im-
portantly, pIgR2/2 mice present a unique opportunity to
explore the relative contribution of secretory antibodies
versus systemic immunity in protection against mucosal
pathogens and maintenance of immune tolerance. Such
studies may promote a rational development of efficient
mucosal vaccines.
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